These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 23859617)

  • 1. Targeting SREBP-1-driven lipid metabolism to treat cancer.
    Guo D; Bell EH; Mischel P; Chakravarti A
    Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
    Guo D; Reinitz F; Youssef M; Hong C; Nathanson D; Akhavan D; Kuga D; Amzajerdi AN; Soto H; Zhu S; Babic I; Tanaka K; Dang J; Iwanami A; Gini B; Dejesus J; Lisiero DD; Huang TT; Prins RM; Wen PY; Robins HI; Prados MD; Deangelis LM; Mellinghoff IK; Mehta MP; James CD; Chakravarti A; Cloughesy TF; Tontonoz P; Mischel PS
    Cancer Discov; 2011 Oct; 1(5):442-56. PubMed ID: 22059152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
    Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
    Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
    Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
    Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α increases lipogenesis via JNK and PI3K/Akt pathways in SZ95 human sebocytes.
    Choi JJ; Park MY; Lee HJ; Yoon DY; Lim Y; Hyun JW; Zouboulis CC; Jin M
    J Dermatol Sci; 2012 Mar; 65(3):179-88. PubMed ID: 22305016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin-induced upregulation of lipogenesis via EGFR/AKT/GSK3β pathway promotes breast cancer cell growth.
    Rajput PK; Varghese JF; Srivastava AK; Kumar U; Yadav UCS
    Cell Signal; 2023 Jul; 107():110686. PubMed ID: 37084841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.
    Yamauchi Y; Furukawa K; Hamamura K; Furukawa K
    Cancer Res; 2011 Jul; 71(14):4989-97. PubMed ID: 21632551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
    Yang YA; Han WF; Morin PJ; Chrest FJ; Pizer ES
    Exp Cell Res; 2002 Sep; 279(1):80-90. PubMed ID: 12213216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydatin Improves Glucose and Lipid Metabolisms in Insulin-Resistant HepG2 Cells through the AMPK Pathway.
    Hao J; Huang K; Chen C; Liang Y; Wang Y; Zhang X; Huang H
    Biol Pharm Bull; 2018; 41(6):891-898. PubMed ID: 29863077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Akt-SREBP nexus: cell signaling meets lipid metabolism.
    Krycer JR; Sharpe LJ; Luu W; Brown AJ
    Trends Endocrinol Metab; 2010 May; 21(5):268-76. PubMed ID: 20117946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
    Porstmann T; Griffiths B; Chung YL; Delpuech O; Griffiths JR; Downward J; Schulze A
    Oncogene; 2005 Sep; 24(43):6465-81. PubMed ID: 16007182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
    Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
    Hao J; Chen C; Huang K; Huang J; Li J; Liu P; Huang H
    Eur J Pharmacol; 2014 Dec; 745():152-65. PubMed ID: 25310908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-β1.
    Hao J; Liu S; Zhao S; Liu Q; Lv X; Chen H; Niu Y; Duan H
    Histochem Cell Biol; 2011 Feb; 135(2):173-81. PubMed ID: 21240525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.
    Guo D; Prins RM; Dang J; Kuga D; Iwanami A; Soto H; Lin KY; Huang TT; Akhavan D; Hock MB; Zhu S; Kofman AA; Bensinger SJ; Yong WH; Vinters HV; Horvath S; Watson AD; Kuhn JG; Robins HI; Mehta MP; Wen PY; DeAngelis LM; Prados MD; Mellinghoff IK; Cloughesy TF; Mischel PS
    Sci Signal; 2009 Dec; 2(101):ra82. PubMed ID: 20009104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Chi X; Qu N; Wang C
    Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-Mediated N-glycosylation of SCAP Is Essential for SREBP-1 Activation and Tumor Growth.
    Cheng C; Ru P; Geng F; Liu J; Yoo JY; Wu X; Cheng X; Euthine V; Hu P; Guo JY; Lefai E; Kaur B; Nohturfft A; Ma J; Chakravarti A; Guo D
    Cancer Cell; 2015 Nov; 28(5):569-581. PubMed ID: 26555173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.